Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents. - Wikidata - awgldk - TriplyDB

Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents.

Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents.

http://www.wikidata.org/entity/Q34159581

about

Treatment of recurrent aphthous stomatitis. A literature review Low-level laser therapy in the treatment of recurrent aphthous ulcers: a systematic review Oral complications of cancer and cancer therapy: from cancer treatment to survivorship.Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis Orofacial manifestations of gastrointestinal disorders.An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial.A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations.

P2860

Q27006851-6F7F3087-6B51-4722-B898-B43EFB9E9637 Q28081210-BBB2D821-96EE-4F01-BFC1-4A057C1477EB Q34299445-3D38B800-FE9F-4319-8ABA-34E5C7F804AE Q37192194-29CE3650-6003-4D8F-B050-9082CEE97436 Q38248663-EAC69F1F-0F70-44F0-AD0F-8303F4920161 Q38979469-21DD75D0-AB30-4DF4-BB0D-37C6A5E0052F Q41159576-5BF03D7D-E1AA-4D83-9408-4C7039A3E1D3

P2860

Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents.

http://www.wikidata.org/entity/Q34159581

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@ast

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@en

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@nl

type

label

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@ast

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@en

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@nl

prefLabel

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@ast

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@en

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@nl

P1433

Q34159581-149D9739-C513-45A9-A61B-36CA8B249DBF

P1476

Q34159581-2F9529DA-D659-4F4D-8DB1-B286600EC61F

P2093

Q34159581-0210A454-92B2-43CA-AFD2-C7D3C8932CCA

Q34159581-675F2003-A4FE-478A-BF0A-CB33EE0EE7CA

Q34159581-C565065E-2B83-4F1B-BEBE-6560736D57BD

Q34159581-C855C3CF-A3A1-45AB-9530-B7EB9AE60B62

Q34159581-CA52888E-6480-44B3-BAE4-038BF0A10281

Q34159581-DCBD7E4E-F6A8-4732-A81C-BDFFCEC7B6A3

P2860

Q34159581-105FEE6B-11C2-4874-A53B-038B3E5B0472

Q34159581-121ADA59-6A55-4D24-860F-72CCF342D696

Q34159581-19404DF3-C6E4-486D-B179-2B3FBA57A203

Q34159581-1E1EE8AA-822A-4C57-BF11-24D39788404A

Q34159581-27DAC02B-F5B1-4536-A9C3-D28845814944

Q34159581-2F9B0515-470C-4A42-92FA-8F94CFDCAB4D

Q34159581-4454C58D-443B-40A9-8F50-F8F360FFB73D

Q34159581-47FE42A8-46D7-40EE-8494-D08C5D90E457

Q34159581-4CAE2C5A-F0BA-431A-AF83-83113BEC890B

Q34159581-5614C21A-DA89-4D10-8DB4-4A2B19C622F5

P304

Q34159581-C63A743F-F278-4A54-A3B4-66BC851FB33F

P31

Q34159581-AA10ADFF-0558-4AD9-84A3-041F70487251

P356

Q34159581-ADA5B900-D7B1-47BD-B653-1DC57467558E

P407

Q34159581-82297872-2392-40F5-AE18-E386201CFFB1

P433

Q34159581-1CB83FBA-FD48-472C-9A39-B2570E427148

P478

Q34159581-7BBFFAF8-45D5-4E95-9C0F-4DBA395BA8DA

P577

Q34159581-85D9F15F-27CE-48D6-99A8-45ABDB591094

P698

Q34159581-35638105-6445-4231-9CD2-6360E9D393E2

P356

14728214.2011.528390

P1433

Expert Opinion on Emerging Drugs

P1476

Topical immunomodulators for m ...... Part II: miscellaneous agents.

@en

P2093

Inger von Bültzingslöwen

http://www.w3.org/2001/XMLSchema#string

Joel B Epstein

http://www.w3.org/2001/XMLSchema#string

Noam Yarom

http://www.w3.org/2001/XMLSchema#string

Rinat Tzach

http://www.w3.org/2001/XMLSchema#string

Scott Drucker

http://www.w3.org/2001/XMLSchema#string

Sharon Elad

http://www.w3.org/2001/XMLSchema#string

P2860

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.

Treatment of focal epithelial hyperplasia with topical imiquimod: report of three cases.

The role of mTOR in memory CD8 T-cell differentiation

Advances in immunosuppressive therapy.

The effect of retinoids on premalignant oral lesions: focus on topical therapy.

Tetracycline therapy: update.

Tetracyclines: nonantibiotic properties and their clinical implications.

A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial.

Calcineurin inhibitors in oral medicine.

Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors.

P304

183-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2011.528390

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21244328

http://www.w3.org/2001/XMLSchema#string